FIELD: medicine.
SUBSTANCE: invention can be used for treatment of hepatic cirrhosis of various aetiologies. For this purpose, in case of hepatic cirrhosis of alimentary aetiology use is made, under pressure of complex therapy, of mesenchymal stromal cells in a dose of 180-190×106 cells twice within 7 days, and, in case of hepatic cirrhosis of HCV etiology - of 200-210×106 cells three times within 7 days, in case of primary biliary cirrhosis - of 220-240×106 cells three times within 9 days.
EFFECT: method increases efficiency of treatment of hepatic cirrhosis of various aetiologies.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING VARIX DILATATION OF ESOPHAGUS IN CASE OF PORTAL HYPERTENSION | 2010 |
|
RU2435591C1 |
| DIAGNOSTIC TECHNIQUE FOR DRUG-INDUCED LIVER INJURY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2695021C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS OF ALCOHOLIC AETIOLOGY | 2011 |
|
RU2477482C1 |
| METHOD OF DETERMINING DEGREE OF SEVERITY OF TISSUE HYPOXIA IN CHRONIC DIFFUSE HEPATIC DISEASE | 2011 |
|
RU2463611C1 |
| DIAGNOSTIC TECHNIQUE FOR CROSSED FORMS OF AUTOIMMUNE LIVER DISEASES | 2011 |
|
RU2477486C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386134C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR LIVER DISEASES OF VARIOUS AETIOLOGIES ACCOMPANIED WITH INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386969C2 |
| METHOD FOR DIAGNOSING HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE WITH TYPE 2 DIABETES MELLITUS | 2019 |
|
RU2732526C1 |
| RADIONUCLIDE METHOD FOR DETERMINING LIVER DYSFUNCTION AFTER ORTHOTOPIC TRANSPLANTATION | 2019 |
|
RU2718294C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
